FIELD: biotechnology.
SUBSTANCE: present invention relates to the field of biotechnology, in particular to new polypeptide for therapy of different tumor diseases; it can be used in medicine. The invention allows for obtaining polypeptide containing at least four different tumor-specific neoantigens fused with at least one amino acid sequence of T-cell amplifier. Compositions containing, in a mixture of separately, a vaccine containing therapeutic polypeptide, a vector or a collection of vectors, according to the present invention, and at least one modulator of a molecule, which is a control point, or an immunomodulator of another type for use in the treatment of cancer, are disclosed.
EFFECT: obtaining compositions for the treatment of cancer.
18 cl, 5 ex, 3 tbl, 8 dwg
Title | Year | Author | Number |
---|---|---|---|
NEOANTIGENS AND THEIR APPLICATION METHODS | 2017 |
|
RU2773273C2 |
THERAPEUTIC ANTI-CANCER NEOEPITOPE VACCINE | 2017 |
|
RU2782422C2 |
ANTIBODY-DRUG CONJUGATES CONTAINING HERBOXYDIENE-BASED SPLICING MODULATOR, AND METHODS OF USE THEREOF | 2019 |
|
RU2820607C2 |
T-CELL RECEPTOR CONSTRUCTS AND THEIR USE | 2019 |
|
RU2785954C2 |
COMPOSITIONS OF VACCINES AGAINST NEOPLASIA AND METHODS FOR OBTAINING THEREOF | 2016 |
|
RU2753246C2 |
BIOLOGICAL MATERIALS FOR MODULATING IMMUNE RESPONSES | 2017 |
|
RU2770060C2 |
NEOANTIGENS AND THEIR USE | 2019 |
|
RU2813924C2 |
NEOANTIGENS AND THEIR APPLICATION | 2019 |
|
RU2805196C2 |
COMPOSITION FOR RELIEVING OR TREATING PAIN | 2017 |
|
RU2725830C1 |
UNIVERSAL VACCINE BASED ON COMMON TUMOR NEOANTIGENS FOR THE PREVENTION AND TREATMENT OF CANCER WITH MICROSATELLITE INSTABILITY (MSI) | 2018 |
|
RU2792843C2 |
Authors
Dates
2022-10-25—Published
2018-07-12—Filed